Schizophrenia

NEI Schizophrenia

NEI Schizophrenia GUIDELINES app brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/364190

Contents of this Issue

Navigation

Page 12 of 19

11 Table 3. Injectable Depot Formulations Medication (Brand) Recommended Dose Range (mg/day) a Half-life (hours) Drug Interactions a Atypical antipsychotic agents Aripiprazole (Abilify Maintena ™ ) 400 mg IM monthly (may reduce to 300) 400 mg-46.5 days 300 mg-29.9 days CYP 3A4 and CYP 2D6 interactions but no specific dose change recommendations Olanzapine (Relprevv ® ) 150 mg/2 wks, 300 mg/4 wks, 210 mg/2 wks, 405 mg/4 wks, or 300 mg/2 wks (See PI for details) ~30 days Diazepam, alcohol, CYP 1A2 and CYP 2D6 interactions but no specific dose change recommendations Paliperidone (Invega ® Sustenna ® ) 117 mg monthly 25-49 days CYP 3A4 interactions but no specific dose change recommendations Risperidone (Consta ® ) 25 mg/2 wks 3-6 days Avoid alcohol, levodopa, dopamine, cimetidine, ranitidine, clozapine, fluoxetine, paroxetine and carbamazepine interactions a Dose range recommendations are adapted from the 2009 Schizophrenia Patient Outcome Research Team recommendations. See full prescribing information for details.

Articles in this issue

Archives of this issue

view archives of Schizophrenia - NEI Schizophrenia